Ogurlu M, Sari S, Küçük M, Bakis M, Ugur B, Eshraghi Y E, Galimberti F, Turan A
Department of Anesthesiology and Reanimation, Adnan Menderes University, Aydin, Turkey.
Anaesth Intensive Care. 2014 May;42(3):365-70. doi: 10.1177/0310057X1404200314.
There is some evidence that propofol may reduce acute postoperative pain; however, the results are inconsistent. Furthermore, there is a paucity of information about the type of anaesthesia and chronic pain. This study was designed to evaluate the hypothesis that propofol reduces acute and chronic postoperative pain compared with sevoflurane. In a randomised, prospective, double-blind trial, we assigned 80 patients having open total abdominal hysterectomy surgery to anaesthesia with either sevoflurane or propofol. Anaesthesia was titrated to clinical needs and bispectral index values to between 40 and 60. Postoperative pain was managed with pethidine and diclofenac. Acute postoperative pain for 24 hours and chronic postoperative pain at one and three months after surgery were evaluated. The Hospital Anxiety and Depression Scale was used to evaluate patient anxiety and depression after one and three months. There were no significant differences between the groups for opioid consumption or opioid-induced side-effects. Pain scores in the first four hours were significantly higher in the sevoflurane group. Persistent surgical pain was observed less frequently (7 out of 40 patients in the propofol group and 21 out of 40 in the sevoflurane group at three months post-surgery, P <0.01) and pain scores were lower at one and three months in the propofol group (0.78±0.55 versus 2.23±0.73 for the sevoflurane group at three months post-surgery, P <0.01). Anxiety and depression scores were significantly lower in the propofol group at three months. In this study, general anaesthesia with propofol was associated with reduced early acute postoperative and persistent pain, compared to sevoflurane-based anaesthesia, among patients undergoing open abdominal hysterectomy.
有证据表明丙泊酚可能减轻术后急性疼痛;然而,结果并不一致。此外,关于麻醉类型与慢性疼痛的信息匮乏。本研究旨在评估与七氟醚相比,丙泊酚可减轻术后急性和慢性疼痛这一假说。在一项随机、前瞻性、双盲试验中,我们将80例行开放性全腹子宫切除术的患者随机分配接受七氟醚或丙泊酚麻醉。根据临床需要和脑电双频指数值将麻醉深度调整至40至60之间。术后疼痛采用哌替啶和双氯芬酸处理。评估术后24小时的急性疼痛以及术后1个月和3个月的慢性疼痛。使用医院焦虑抑郁量表评估术后1个月和3个月时患者的焦虑和抑郁情况。两组在阿片类药物用量或阿片类药物引起的副作用方面无显著差异。七氟醚组在前4小时的疼痛评分显著更高。术后3个月时,丙泊酚组持续性手术疼痛的发生率更低(丙泊酚组40例患者中有7例,七氟醚组40例患者中有21例,P<0.01),且丙泊酚组在术后1个月和3个月时的疼痛评分更低(术后3个月时,七氟醚组为2.23±0.73,丙泊酚组为0.78±0.55,P<0.01)。丙泊酚组在术后3个月时的焦虑和抑郁评分显著更低。在本研究中,对于接受开放性腹式子宫切除术的患者,与基于七氟醚的麻醉相比,丙泊酚全身麻醉与早期术后急性疼痛和持续性疼痛减轻相关。